Activity Chair:
Michael Miller, MD, FACC, FAHA
Professor of Cardiovascular Medicine, Epidemiology & Public Health
University of Maryland School of Medicine
Director, Center for Preventive Cardiology
University of Maryland Medical Center
Cardiology Division
Baltimore, MD
Faculty:
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Professor of Medicine, Harvard Medical School
Chief of Cardiology
VA Boston Healthcare
Director, Integrated Interventional Cardiovascular Program
Brigham and Women's Hospital & VA Boston Healthcare
Boston, MA
James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA
Lipidology & Cardiovascular Disease Prevention
Clinical Assistant Professor of Medicine
NYU Medical School & NYU Center for CV Prevention
Director, Bellevue Hospital Lipid Clinic
New York, NY
Robert P. Giugliano, MD, SM, FACC, FAHA
Senior Investigator, TIMI Study Group
Physician, Cardiovascular Medicine
Brigham and Women's Hospital
Associate Professor
Harvard Medical School
Boston, MA
Robert S. Rosenson, MD, FACC, FACP, FAHA, FNLA
Professor of Medicine, Cardiology
Icahn School of Medicine at Mount Sinai
Director, Cardiometabolic Disorders
Mount Sinai Heart
New York, NY
Reviewer:
Ronald A. Codario, MD, FACP, FNLA, RPVI, CHCP
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears on this page and the next page.
Activity Chair, Planning Committee, and Faculty members report the following relationship(s):
Michael Miller, MD, FACC, FAHA
Contracted Research: Amgen
Steering Committee: Pfizer, Spire
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI
Research Funding (Paid to institution): Amarin, Amgen, AstraZeneca (PI), Bristol-Myers Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix (PI), Medtronic (PI), Pfizer, Roche, Sanofi Aventis, The Medicines Company (PI)
Robert P. Giugliano, MD, SM, FACC, FAHA
Consulting Fee: Amarin, American College of Cardiology, Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, CVS Caremark, Daiichi Sankyo, GlaxoSmithKline, Lexicon, Merck, Portola, Pfizer, St. Jude, Stealth Peptides
Contracted Research: Amgen
Honorarium for CME Lectures: Amgen, Daiichi Sankyo, Merck
Robert S. Rosenson, MD, FACC, FACP, FAHA, FNLA
Royalties: UpToDate
Consulting Fee: Akcea, Amgen, AstraZeneca, Eli Lilly, GlaxoSmithKline, Regeneron, Sanofi
Honoraria: Kowa
James A. Underberg, MD, MS, FACPM, FACP, FASH, FNLA
Consulting Fee: Aegerion, Alexion, Akcea, Amarin, Amgen, AstraZeneca, Gemphire, Invitae, Sanofi, Synageva
Speakers Bureau: Alexion, Amgen, AstraZeneca, Genzyme, Merck, Sanofi
Contracted Research: Aegerion, Gemphire, Pfizer
Reviewer reports the following relationship(s):
Ronald Codario, MD, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.